Scleromyxoedema-like changes in four renal dialysis patients.
We describe four renal dialysis patients from our hospital who, over a 6-month period, developed erythematous, thickened, indurated dermal plaques. The plaques were limited to the limbs and in three patients there were associated flexion contractures. The clinical features most resembled scleromyxoedema. All patients had previously received at least one renal transplant. Histopathology of the plaques showed features of scleromyxoedema in two patients, whereas the other two showed a different picture, more suggestive of a morphoea-like process. There are important differences between our patients and classical scleromyxoedema. All four patients had normal immunoglobulins and no paraprotein was detected. Almost all cases of classical scleromyxoedema are associated with an IgGlambda paraproteinaemia. We have not yet identified an underlying cause for this cluster of cases in our hospital. It is possible that the skin changes seen may have been precipitated by an environmental agent, such as in 'toxic oil syndrome' and vinyl chloride-induced scleroderma. We discuss the differences between our patients and those with scleromyxoedema, localized or generalized morphoea and environmentally induced scleroderma. We feel that our patients show a constellation of features similar, but not identical, to scleromyxoedema. There has been only one previous report of similar patients. We believe this to be a new and distinct phenomenon.
Hubbard
V
V
Department of Dermatology, The Royal Free Hospital, Pond Street, London NW3 2QG, UK. ginny@vhubbard.fsbusiness.co.uk
Davenport
A
A
Jarmulowicz
M
M
Rustin
M
M
D000328:Adult; D001706:Biopsy; D005260:Female; D006229:Hand Dermatoses / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D007868:Leg Dermatoses / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000473:pathology* / Q000628:therapy; D006435:Renal Dialysis; D012594:Scleroderma, Localized / Q000150:complications* / Q000628:therapy